poster session

Spread the meeting

POSTER SESSION

P01 – “The impact of Akkermansia muciniphila on bone health.” Abdollahiyan Sarah. (abstract P01)

P02 – “The Relative Abundance of Important Gut Microbiota Members in Iranian CVD Patients.” Ahmadi Badi Sara. (abstract P02)

P03 – Akkermansia muciniphila-derived extracellular vesicles ameliorate obesity by impact on tight junction protein, inflammation and energy homeostasis. Ashrafian Fatemeh. (abstract P03)

P04 – “Probiotic modulation of dendritic cell function in Crohn’s disease patients.Baradaran Ghavami Shaghayegh. (abstract P04)

P05 – “Gut microbiota, subclinical carotid atherosclerosis and major cardiovascular risk factors in general population: which association?Baragetti Andrea. (abstract P05)

P06 – “Microbiota-driven gut vascular barrier disruption is a prerequisite for NASH development.Brescia Paola. (abstract P06)

P07 – “Gut microbiota alterations affect glioma growth and innate immune cells involved in tumor immunosurveillance.D’Alessandro Giuseppina. (abstract P07)

P08 – “Study of changes in the intestinal microbiota of rats caused by implantation of a biopolymer construct based on poly-3-hydroxybutyrate and alginate.Dudun Andrei. (abstract P08)

P09 – “Alteration of gut microbiota composition in obese adults; a possible link between obesity and fatty liver disease.Ejtahed Hanieh-Sadat. (abstract P09)

P10 – “Characterization of fecal and oral microbiome associated with Lynch syndrome.Ferrarese Roberto. (abstract P10)

P11 – “One month of Ketogenic Diet alters short chain fatty acids production in drug-resistant epileptic patients.Ferraris Cinzia. (abstract P11)

P12 – “Toll-like receptor 4-mediated inflammation triggered by extracellular IFI16 is enhanced by lipopolysaccharide binding.Iannucci Andrea. (abstract P12)

P13 – “Gut microbiota composition in osteopenia and osteoporosis patients.Keshavarz Azizi raftar Shahrbanoo. (abstract P13)

P14 – “Unraveling the Pathways Involved in Gut Vascular Barrier Impairment in Metastatic Colorectal Cancer.Lo Cascio Antonino. (abstract P14)

P15 – “An anti-inflammatory diet enriched in omega3 and inulin prevents Type 1 Diabetes by inducing intestinal Treg cell differentiation and restoring gut barrier integrity in NOD mice. Lo Conte Marta. (abstract P15)

P16 – “Beneficial properties of a symbiontic innovative supplement (PROBIT®; MGP GOLD AND KLUYVEROMYCES MARXIANUS B0399) in antiblastic drugs-induced gastrointestinal side effects.” Mantovani Mauro. (abstract P16)

P17 – “Microbiota Composition in HIV-positive and HIV-Exposed Uninfected Pediatric Subjects.Merlini Esther. (abstract P17)

P18 – “The Airway Microbiota pattern in Cystic Fibrosis.Meskini Maryam. (abstract P18)

P19 – “Microbiota-mediated PROTEIN X expression affects Immune Breast Cancer Microenvironment and Overall Survival.Mozzarelli Alessandro Mauro. (abstract P19)

P20 – “Characterization of the urinary microbiota in bladder cancer patients.Oresta Bianca. (abstract P20)

P21 – “Phenotyping and genotyping of non–Escherichia coli Enterobacteriaceae isolated from the gut microbiota of healthy subjects.Rossi Maddalena. (abstract P21)

P22 – “16S profiling and isolation of mucin degraders from human gut microbiota.Rossi Maddalena. (abstract P22)

P23 – “The Lung and Gut Microbiota in Pulmonary Tuberculosis: A Systemic Review.Abdolhamidi Rouhollah. (abstract P23)

P24 – “Comparability of 16S rRNA gene sequencing in fresh frozen and formalin fixed paraffin embedded colorectal cancer samples.Serna Garazi. (abstract P24)

P25 – “Gut microbiota composition in type 2 diabetic patients.Siadat Seyed Davar. (abstract P25)

P26 – “Biofilm and soluble virulence factors produced by Staphylococcus spp. strains isolated from skin microbiota in people with acne.Silvana-Adelina Gheorghe. (abstract P26)

P27 – “Gut Microbiota and their Metabolites In Colorectal Cancer: A Systematic Review.Tarashi Samira. (abstract P27)

P28 – “Microbial communities in agricultural soil fertilized with animal manure in Northern Italy.Tolosi Roberta. (abstract P28)

P29 – “Soy intake and breast cancer.” Virgili Edy. (abstract P29)

P30 – “Può la modulazione del microbiota migliorare la risposta alla terapia con checkpoint inhibitor? Case-reportZerilli Filippo. (abstract P30)

P31 – “Gut microbiota and B cell receptor (BCR) inhibitors for the treatment of lymphoid malignancies: retrospective recognition of different enterotypes correlated to clinical response or irAEs occurrence. A cross-sectional study.Zuccaro Valentina. (abstract P31)